Standout Papers

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants 2023 2026 2024146
  1. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants (2023)
    Simon B. Drysdale, Katrina Cathie et al. New England Journal of Medicine

Immediate Impact

12 standout
Sub-graph 1 of 6

Citing Papers

Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis
2025 Standout
Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024
2024 Standout

Works of Katrina Cathie being referenced

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
2023 Standout

Author Peers

Author Last Decade Papers Cites
Katrina Cathie 144 78 5 47 13 181
Alice Raillard 70 54 12 33 11 173
Chukwuemeka Onwuchekwa 123 43 5 70 14 190
James Inglis 192 123 2 66 12 295
Livia Piccioni 126 39 9 64 15 186
Fathima Naby 234 95 10 71 11 274
Agnieszka Zareba 228 74 3 120 12 255
Prabhu Shankar 204 63 17 60 11 276
A Rojahn 105 29 7 145 19 251
Karen Ravin 73 47 6 36 13 257
Charles A. LeMaistre 50 28 3 70 14 256

All Works

Loading papers...

Rankless by CCL
2026